| For: | Iudicibus SD, Lucafò M, Martelossi S, Pierobon C, Ventura A, Decorti G. MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. World J Gastroenterol 2013; 19(44): 7947-7954 [PMID: 24307788 DOI: 10.3748/wjg.v19.i44.7947] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i44/7947.htm |
| Number | Citing Articles |
| 1 |
Igor Koturbash, William H Tolleson, Lei Guo, Dianke Yu, Si Chen, Huixiao Hong, William Mattes, Baitang Ning. Micrornas as Pharmacogenomic Biomarkers for Drug Efficacy and Drug Safety Assessment. Biomarkers in Medicine 2015; 9(11) doi: 10.2217/bmm.15.89
|
| 2 |
Xiu-Jun Liao, Wei-Ming Mao, Qin Wang, Guan-Gen Yang, Wen-Jing Wu, Shu-Xian Shao. MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome. Biochemical and Biophysical Research Communications 2016; 469(2) doi: 10.1016/j.bbrc.2015.11.102
|
| 3 |
Emira Ayroldi, Antonio Macchiarulo, Carlo Riccardi. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid‐induced leucine zipper? A perspective. The FASEB Journal 2014; 28(12) doi: 10.1096/fj.14-254755
|
| 4 |
Christopher Chang. Unmet needs in the treatment of autoimmunity: From aspirin to stem cells. Autoimmunity Reviews 2014; 13(4-5) doi: 10.1016/j.autrev.2014.01.052
|
| 5 |
Vipula Kolli, Jacob Trick, Annie Schulman, James R Iben, Cameron Padilla, Tianwei Li, Fabio Rueda Faucz, Deborah P. Merke. Exogenous glucocorticoid dose impacts circulating microRNA expression in patients with adrenal insufficiency due to 21-hydroxylase deficiency. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1784619
|
| 6 |
Anna Stachurska, Maria M. Zorro, Marijke R. van der Sijde, Sebo Withoff. Small and Long Regulatory RNAs in the Immune System and Immune Diseases. Frontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00513
|
| 7 |
Anet A. Soubières, Andrew Poullis. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2016; 22(8) doi: 10.1097/MIB.0000000000000836
|
| 8 |
Marianna Lucafò, Raffaella Franca, Davide Selvestrel, Debora Curci, Letizia Pugnetti, Giuliana Decorti, Gabriele Stocco. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(12) doi: 10.1080/17425255.2018.1551876
|
| 9 |
Ramy Elgendy, Mery Giantin, Clara Montesissa, Mauro Dacasto. Transcriptomic analysis of skeletal muscle from beef cattle exposed to illicit schedules containing dexamethasone: identification of new candidate biomarkers and their validation using samples from a field monitoring trial. Food Additives & Contaminants: Part A 2015; 32(9) doi: 10.1080/19440049.2015.1070307
|
| 10 |
Astrid Luypaert, Wim Vanden Berghe, Jan Tavernier, Claude Libert, Karolien De Bosscher. Immunopharmacology and Inflammation. 2018; doi: 10.1007/978-3-319-77658-3_13
|
| 11 |
Cinzia Ciccacci, Sara Rufini, Cristina Politi, Giuseppe Novelli, Vittorio Forte, Paola Borgiani. Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes. Thrombosis Research 2015; 136(2) doi: 10.1016/j.thromres.2015.06.026
|
| 12 |
Joelynn Dailey, Jeffrey S. Hyams. Pediatric Inflammatory Bowel Disease. 2023; doi: 10.1007/978-3-031-14744-9_8
|
| 13 |
Tianfeng Yang, Juan Luo, Junrui Tang, Jing Wu, Shuxian Xia, Maojuan Li, Qi Huang, Gang Yang, Jiarong Miao, Yunzhen Zhu. miR-16-2-3p enhances glucocorticoid sensitivity in ulcerative colitis by targeting CREB1 and NF-κB1. Human Cell 2026; 39(6) doi: 10.1007/s13577-026-01395-z
|
| 14 |
Arunoday Bhan, Paromita Deb, Milad Soleimani, Subhrangsu S. Mandal. Gene Regulation, Epigenetics and Hormone Signaling. 2017; doi: 10.1002/9783527697274.ch5
|
| 15 |
Lei Ye, Xiaowei Wu, Na Yu, Jingxin Pan, Lianming Liao, Fangyu Wang. Clinical efficacy and safety of stem cells in refractory Crohn's disease: A systematic review. Journal of Cellular Immunotherapy 2016; 2(1) doi: 10.1016/j.jocit.2016.01.001
|
| 16 |
Peter Townsend, Jeffrey S. Hyams. Pediatric Inflammatory Bowel Disease. 2017; doi: 10.1007/978-3-319-49215-5_8
|
| 17 |
Jan Däbritz, Trevelyan R. Menheniott. Linking Immunity, Epigenetics, and Cancer in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(9) doi: 10.1097/MIB.0000000000000063
|
| 18 |
Maria Cappello, Gaetano Cristian Morreale. The Role of Laboratory Tests in Crohn's Disease. Clinical Medicine Insights: Gastroenterology 2016; 9 doi: 10.4137/CGast.S38203
|
| 19 |
Weiwei Jiang, Xuhang Li. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Molecular Diagnosis & Therapy 2015; 19(3) doi: 10.1007/s40291-015-0142-7
|
| 20 |
Guodong Chen, Shan Cao, Feng Liu, Yulan Liu.
miR-195 plays a role in steroid resistance of ulcerative colitis by targeting Smad7. Biochemical Journal 2015; 471(3) doi: 10.1042/BJ20150095
|
| 21 |
H. Kang, H. Chen, P. Huang, J. Qi, N. Qian, L. Deng, L. Guo. Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p. Osteoporosis International 2016; 27(4) doi: 10.1007/s00198-015-3381-x
|
| 22 |
Liyun Shen, Fengjiao Huang, Lei Ye, Wei Zhu, Xiaofang Zhang, Shu Wang, Weiqing Wang, Guang Ning. Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves’ ophthalmopathy. Endocrine 2015; 49(2) doi: 10.1007/s12020-014-0487-4
|
| 23 |
Marianna Lucafò, Daria Sicari, Andrea Chicco, Debora Curci, Arianna Bellazzo, Alessia Di Silvestre, Chiara Pegolo, Robert Autry, Erika Cecchin, Sara De Iudicibus, Licio Collavin, William Evans, Giuliana Decorti, Gabriele Stocco. miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway. Cancer Chemotherapy and Pharmacology 2020; 86(3) doi: 10.1007/s00280-020-04122-z
|
| 24 |
Emilio G Quetglas, Zlatan Mujagic, Simone Wigge, Daniel Keszthelyi, Sebastian Wachten, Ad Masclee, Walter Reinisch. Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World Journal of Gastroenterology 2015; 21(44): 12519-12543 doi: 10.3748/wjg.v21.i44.12519
|
| 25 |
Iván Igaz, Mihály Szőnyi, Patrícia Varga, Lajos Topa. Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases. Orvosi Hetilap 2014; 155(13) doi: 10.1556/OH.2014.29864
|
| 26 |
Stefania Croci, Alessandro Zerbini, Luigi Boiardi, Francesco Muratore, Alessandra Bisagni, Davide Nicoli, Enrico Farnetti, Giulia Pazzola, Luca Cimino, Antonio Moramarco, Alberto Cavazza, Bruno Casali, Maria Parmeggiani, Carlo Salvarani. MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis. Annals of the Rheumatic Diseases 2016; 75(8) doi: 10.1136/annrheumdis-2015-207846
|
| 27 |
Changgui Shi, Ping Huang, Hui Kang, Bo Hu, Jin Qi, Min Jiang, Hanbing Zhou, Lei Guo, Lianfu Deng. Glucocorticoid inhibits cell proliferation in differentiating osteoblasts by microRNA-199a targeting of WNT signaling. Journal of Molecular Endocrinology 2015; 54(3) doi: 10.1530/JME-14-0314
|